{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:21:45Z","timestamp":1789759305885,"version":"4.0.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Preeclampsia (PE) and peripartum sepsis are two complications of pregnancy and are often associated with disturbed renal function due possibly to dysregulated renin angiotensin system. Here we evaluated hemodynamic and renal consequences of separate and combined PE and sepsis insults in weaning mothers and tested whether this interaction is influenced by prenatally-administered losartan (AT1-receptor blocker) or pioglitazone (PPAR\u03b3 agonist). The PE-rises in blood pressure and proteinuria induced by gestational nitric oxide synthase inhibition (L-NAME, 50 mg\/kg\/day for 7 days) were attenuated after simultaneous treatment with losartan or pioglitazone. These drugs further improved glomerular and tubular structural defects and impaired vasodilatory responses evoked by adenosinergic (N-ethylcarboxamidoadenosine) or cholinergic (acetylcholine) receptor activation in perfused kidneys of weaning dams. Likewise, treatment of weaning PE dams with a single 4-h dosing of lipopolysaccharides (LPS, 5 mg\/kg) weakened renal structural damage, enhanced renal vasodilations and accentuated the upregulated vasodilatory response set off by losartan or pioglitazone. Molecularly, the favorable effect of pharmacologic or endotoxic intervention was coupled with dampened tubular and glomerular expressions of inflammatory (toll-like receptor 4) and apoptotic signals (caspase-3). Our data unveil beneficial and possibly intensified conditioning effect for endotoxemia when combined with losartan or pioglitazone against preeclamptic renovascular dysfunction and inflammation.<\/jats:p>","DOI":"10.1038\/s41598-025-87586-4","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:34:27Z","timestamp":1741458867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacologic and endotoxic reprogramming of renal vasodilatory, inflammatory, and apoptotic blemishes in weaning preeclamptic rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Hagar A.","family":"Morgaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Y.","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevine M.","family":"El-Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan M.","family":"El-Gowelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"El-Gowilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"El-Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"87586_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ekir.2018.01.011","volume":"3","author":"S Rao","year":"2018","unstructured":"Rao, S. & Jim, B. Acute kidney injury in pregnancy: The changing landscape for the 21st century. Kidney Int. rep. 3, 247\u2013257. https:\/\/doi.org\/10.1016\/j.ekir.2018.01.011 (2018).","journal-title":"Kidney Int. rep."},{"key":"87586_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0002-9378(98)70254-6","volume":"179","author":"GP Sacks","year":"1998","unstructured":"Sacks, G. P., Studena, K., Sargent, K. & Redman, C. W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol. 179, 80\u201386. https:\/\/doi.org\/10.1016\/s0002-9378(98)70254-6 (1998).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"87586_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1573396316666191224092405","volume":"16","author":"AA Karatza","year":"2020","unstructured":"Karatza, A. A. & Dimitriou, G. Preeclampsia emerging as a novel risk factor for cardiovascular disease in the offspring. Curr. Pediatr. Rev. 16, 194\u2013199. https:\/\/doi.org\/10.2174\/1573396316666191224092405 (2020).","journal-title":"Curr. Pediatr. Rev."},{"key":"87586_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","volume":"4","author":"AL Tranquilli","year":"2014","unstructured":"Tranquilli, A. L. et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy hypertens. 4, 97\u2013104. https:\/\/doi.org\/10.1016\/j.preghy.2014.02.001 (2014).","journal-title":"Pregnancy hypertens."},{"key":"87586_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.biopha.2018.10.082","volume":"109","author":"H Moghaddas Sani","year":"2019","unstructured":"Moghaddas Sani, H., Zununi Vahed, S. & Ardalan, M. Preeclampsia: A close look at renal dysfunction. Biomed. Pharmacother.= Biomed. Pharmacother. 109, 408\u2013416. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.082 (2019).","journal-title":"Biomed. Pharmacother.= Biomed. Pharmacother."},{"key":"87586_CR6","doi-asserted-by":"publisher","first-page":"S819","DOI":"10.1016\/j.ajog.2020.08.108","volume":"226","author":"M Fishel Bartal","year":"2022","unstructured":"Fishel Bartal, M., Lindheimer, M. D. & Sibai, B. M. Proteinuria during pregnancy: Definition, pathophysiology, methodology, and clinical significance. Am. J. Obstet. Gynecol. 226, S819\u2013S834. https:\/\/doi.org\/10.1016\/j.ajog.2020.08.108 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"87586_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/cs20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon, A. C. et al. The role of inflammation in the pathology of preeclampsia. Clin. Sci. (Lond. Engl.: 1979) 130, 409\u2013419. https:\/\/doi.org\/10.1042\/cs20150702 (2016).","journal-title":"Clin. Sci. (Lond. Engl.: 1979)"},{"key":"87586_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/1179545x17752325","author":"DC Cornelius","year":"2018","unstructured":"Cornelius, D. C. Preeclampsia: From Inflammation to Immunoregulation. Clin. Med. insights. Blood disord. https:\/\/doi.org\/10.1177\/1179545x17752325 (2018).","journal-title":"Clin. Med. insights. Blood disord."},{"key":"87586_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114703","volume":"192","author":"AM Wedn","year":"2021","unstructured":"Wedn, A. M., El-Bassossy, H. M., Eid, A. H. & El-Mas, M. M. Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: Therapeutic perspectives. Biochem. Pharmacol. 192, 114703. https:\/\/doi.org\/10.1016\/j.bcp.2021.114703 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"87586_CR10","doi-asserted-by":"publisher","first-page":"F1315","DOI":"10.1152\/ajprenal.00071.2020","volume":"318","author":"HR Turbeville","year":"2020","unstructured":"Turbeville, H. R. & Sasser, J. M. Preeclampsia beyond pregnancy: Long-term consequences for mother and child. Am. J. Physiol. Ren. Physiol. 318, F1315\u2013F1326. https:\/\/doi.org\/10.1152\/ajprenal.00071.2020 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"87586_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13224-022-01706-y","volume":"72","author":"AH Nayak","year":"2022","unstructured":"Nayak, A. H. & Khade, S. A. Obstetric sepsis: A review article. J. obstet. Gynaecol. India 72, 470\u2013478. https:\/\/doi.org\/10.1007\/s13224-022-01706-y (2022).","journal-title":"J. obstet. Gynaecol. India"},{"key":"87586_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijoa.2019.05.010","volume":"40","author":"S Einav","year":"2019","unstructured":"Einav, S. & Leone, M. Epidemiology of obstetric critical illness. Int. J. obstet. Anesth. 40, 128\u2013139. https:\/\/doi.org\/10.1016\/j.ijoa.2019.05.010 (2019).","journal-title":"Int. J. obstet. Anesth."},{"key":"87586_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119578","author":"L Cai","year":"2023","unstructured":"Cai, L., Rodgers, E., Schoenmann, N. & Raju, R. P. Advances in rodent experimental models of sepsis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24119578 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"87586_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1039\/b500756a","volume":"1","author":"VM Bhor","year":"2005","unstructured":"Bhor, V. M., Thomas, C. J., Surolia, N. & Surolia, A. Polymyxin B: An ode to an old antidote for endotoxic shock. Mol. Biosyst. 1, 213\u2013222. https:\/\/doi.org\/10.1039\/b500756a (2005).","journal-title":"Mol. Biosyst."},{"key":"87586_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vph.2014.04.005","volume":"62","author":"S Zhang","year":"2014","unstructured":"Zhang, S. et al. Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors. Vasc. Pharmacol. 62, 15\u201323. https:\/\/doi.org\/10.1016\/j.vph.2014.04.005 (2014).","journal-title":"Vasc. Pharmacol."},{"key":"87586_CR16","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.26355\/eurrev_201808_15742","volume":"22","author":"CH Chuang","year":"2018","unstructured":"Chuang, C. H., Yang, C. K., Wu, P. H., Zhang, Y. & Yang, P. J. Acute renal injury induced by endotoxic shock in rats is alleviated via PI3K\/Nrf2 pathway. Eur. Rev. Med. Pharmacol. Sci. 22, 5394\u20135401. https:\/\/doi.org\/10.26355\/eurrev_201808_15742 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"87586_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/shk.0000000000000295","volume":"43","author":"HH Shen","year":"2015","unstructured":"Shen, H. H. et al. Alpha-lipoic acid prevents endotoxic shock and multiple organ dysfunction syndrome induced by endotoxemia in rats. Shock (Augusta, Ga.) 43, 405\u2013411. https:\/\/doi.org\/10.1097\/shk.0000000000000295 (2015).","journal-title":"Shock (Augusta, Ga.)"},{"key":"87586_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jsps.2019.11.014","volume":"28","author":"AM Wedn","year":"2020","unstructured":"Wedn, A. M., El-Gowilly, S. M. & El-Mas, M. M. Time and sex dependency of hemodynamic, renal, and survivability effects of endotoxemia in rats. Saudi pharma. J.: SPJ: off. Publ. Saudi Pharm. Soc. 28, 127\u2013135. https:\/\/doi.org\/10.1016\/j.jsps.2019.11.014 (2020).","journal-title":"Saudi pharma. J.: SPJ: off. Publ. Saudi Pharm. Soc."},{"key":"87586_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020379","author":"L Mazgaeen","year":"2020","unstructured":"Mazgaeen, L. & Gurung, P. Recent advances in lipopolysaccharide recognition systems. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21020379 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"87586_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"Chousterman, B. G., Swirski, F. K. & Weber, G. F. Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 39, 517\u2013528. https:\/\/doi.org\/10.1007\/s00281-017-0639-8 (2017).","journal-title":"Semin. Immunopathol."},{"key":"87586_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/mcc.0000000000000356","volume":"22","author":"H G\u00f3mez","year":"2016","unstructured":"G\u00f3mez, H. & Kellum, J. A. Sepsis-induced acute kidney injury. Curr. Opin. Crit. Car. 22, 546\u2013553. https:\/\/doi.org\/10.1097\/mcc.0000000000000356 (2016).","journal-title":"Curr. Opin. Crit. Car."},{"key":"87586_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.semnephrol.2017.05.011","volume":"37","author":"B Jim","year":"2017","unstructured":"Jim, B. & Karumanchi, S. A. Preeclampsia: Pathogenesis, prevention, and long-term complications. Semi. Nephrol. 37, 386\u2013397. https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.011 (2017).","journal-title":"Semi. Nephrol."},{"key":"87586_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","volume":"19","author":"E Deer","year":"2023","unstructured":"Deer, E. et al. The role of immune cells and mediators in preeclampsia. Nat. Rev. Nephrol. 19, 257\u2013270. https:\/\/doi.org\/10.1038\/s41581-022-00670-0 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"87586_CR24","doi-asserted-by":"publisher","first-page":"3737890","DOI":"10.1155\/2019\/3737890","volume":"2019","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Increased TLR4 expression aggravates sepsis by promoting IFN-\u03b3 expression in CD38(-\/-) mice. J. Immunol. Res. 2019, 3737890. https:\/\/doi.org\/10.1155\/2019\/3737890 (2019).","journal-title":"J. Immunol. Res."},{"key":"87586_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/636419","volume":"2012","author":"FC Bernardi","year":"2012","unstructured":"Bernardi, F. C. et al. Oxidative damage, inflammation, and Toll-like receptor 4 pathway are increased in preeclamptic patients: A case-control study. Oxid. Med. Cell. Longev. 2012, 636419. https:\/\/doi.org\/10.1155\/2012\/636419 (2012).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"87586_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115963","volume":"220","author":"CR Clark","year":"2024","unstructured":"Clark, C. R. & Khalil, R. A. Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1\u20137)\/MasR signaling in normal and hypertensive pregnancy. Biochem. Pharmacol. 220, 115963. https:\/\/doi.org\/10.1016\/j.bcp.2023.115963 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"87586_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.preghy.2022.01.011","volume":"28","author":"CRV Leal","year":"2022","unstructured":"Leal, C. R. V. et al. Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review. Pregnancy hypertens. 28, 15\u201320. https:\/\/doi.org\/10.1016\/j.preghy.2022.01.011 (2022).","journal-title":"Pregnancy hypertens."},{"key":"87586_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fendo.2019.00563","volume":"10","author":"ER Lumbers","year":"2019","unstructured":"Lumbers, E. R., Delforce, S. J., Arthurs, A. L. & Pringle, K. G. Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia. Front. Endocrinol. 10, 563. https:\/\/doi.org\/10.3389\/fendo.2019.00563 (2019).","journal-title":"Front. Endocrinol."},{"key":"87586_CR29","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/s0002-9378(98)70337-0","volume":"178","author":"TP Doering","year":"1998","unstructured":"Doering, T. P., Haller, N. A., Montgomery, M. A., Freeman, E. J. & Hopkins, M. P. The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. Am. J. obstet. Gynecol. 178, 1307\u20131312. https:\/\/doi.org\/10.1016\/s0002-9378(98)70337-0 (1998).","journal-title":"Am. J. obstet. Gynecol."},{"key":"87586_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm.1856","volume":"14","author":"CC Zhou","year":"2008","unstructured":"Zhou, C. C. et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 14, 855\u2013862. https:\/\/doi.org\/10.1038\/nm.1856 (2008).","journal-title":"Nat. Med."},{"key":"87586_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105916","volume":"174","author":"F Senatore","year":"2021","unstructured":"Senatore, F., Balakumar, P. & Jagadeesh, G. Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management. Pharmacol. Res. 174, 105916. https:\/\/doi.org\/10.1016\/j.phrs.2021.105916 (2021).","journal-title":"Pharmacol. Res."},{"key":"87586_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-015-0802-3","volume":"19","author":"TD Corr\u00eaa","year":"2015","unstructured":"Corr\u00eaa, T. D., Takala, J. & Jakob, S. M. Angiotensin II in septic shock. Crit. care (Lond. Engl.) 19, 98. https:\/\/doi.org\/10.1186\/s13054-015-0802-3 (2015).","journal-title":"Crit. care (Lond. Engl.)"},{"key":"87586_CR33","doi-asserted-by":"publisher","first-page":"F496","DOI":"10.1152\/ajprenal.00121.2014","volume":"311","author":"RM Rosa","year":"2016","unstructured":"Rosa, R. M. et al. Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia. Am. J. Physiol. Ren. Physiol. 311, F496\u2013F504. https:\/\/doi.org\/10.1152\/ajprenal.00121.2014 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"87586_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/01.hyp.38.2.177","volume":"38","author":"M Bucher","year":"2001","unstructured":"Bucher, M., Ittner, K. P., Hobbhahn, J., Taeger, K. & Kurtz, A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertens. (Dallas, Tex.: 1979) 38, 177\u2013182. https:\/\/doi.org\/10.1161\/01.hyp.38.2.177 (2001).","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"key":"87586_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308557","volume":"19","author":"Z Zhan","year":"2024","unstructured":"Zhan, Z., Lian, Z. & Bai, H. Dexamethasone inhibited angiotensin II and its receptors to reduce sepsis-induced lung and kidney injury in rats. PloS one 19, e0308557. https:\/\/doi.org\/10.1371\/journal.pone.0308557 (2024).","journal-title":"PloS one"},{"key":"87586_CR36","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.peptides.2005.03.057","volume":"26","author":"M Fukada","year":"2005","unstructured":"Fukada, M. et al. Systemic administration of lipopolysaccharide upregulates angiotensin II expression in rat renal tubules: Immunohistochemical and ELISA studies. Peptides 26, 2215\u20132221. https:\/\/doi.org\/10.1016\/j.peptides.2005.03.057 (2005).","journal-title":"Peptides"},{"key":"87586_CR37","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00134-003-1986-6","volume":"29","author":"D du Cheyron","year":"2003","unstructured":"du Cheyron, D., Lesage, A., Daubin, C., Ramakers, M. & Charbonneau, P. Hyperreninemic hypoaldosteronism: A possible etiological factor of septic shock-induced acute renal failure. Intens. care Med. 29, 1703\u20131709. https:\/\/doi.org\/10.1007\/s00134-003-1986-6 (2003).","journal-title":"Intens. care Med."},{"key":"87586_CR38","doi-asserted-by":"publisher","first-page":"H3726","DOI":"10.1152\/ajpheart.01116.2007","volume":"293","author":"DD Lund","year":"2007","unstructured":"Lund, D. D., Brooks, R. M., Faraci, F. M. & Heistad, D. D. Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am. J. physiol. Heart. Circ. Physiol. 293, H3726\u2013H3731. https:\/\/doi.org\/10.1152\/ajpheart.01116.2007 (2007).","journal-title":"Am. J. physiol. Heart. Circ. Physiol."},{"key":"87586_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.0001-5172.2004.00283.x","volume":"48","author":"M Laesser","year":"2004","unstructured":"Laesser, M., Oi, Y., Ewert, S., F\u00e4ndriks, L. & Aneman, A. The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model. Acta anaesthesiol. Scand. 48, 198\u2013204. https:\/\/doi.org\/10.1111\/j.0001-5172.2004.00283.x (2004).","journal-title":"Acta anaesthesiol. Scand."},{"key":"87586_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jss.2013.08.004","volume":"186","author":"Y Hirano","year":"2014","unstructured":"Hirano, Y. et al. (Pro)renin receptor blocker improves survival of rats with sepsis. J. surg. Res. 186, 269\u2013277. https:\/\/doi.org\/10.1016\/j.jss.2013.08.004 (2014).","journal-title":"J. surg. Res."},{"key":"87586_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet (Lond. Engl.) 398, 341\u2013354. https:\/\/doi.org\/10.1016\/s0140-6736(20)32335-7 (2021).","journal-title":"Lancet (Lond. Engl.)"},{"key":"87586_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi, M., Evans, L., Levy, M. & Rhodes, A. Sepsis and septic shock. Lancet (Lond. Engl.) 392, 75\u201387. https:\/\/doi.org\/10.1016\/s0140-6736(18)30696-2 (2018).","journal-title":"Lancet (Lond. Engl.)"},{"key":"87586_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067175","volume":"8","author":"CD Acosta","year":"2013","unstructured":"Acosta, C. D. et al. The continuum of maternal sepsis severity: incidence and risk factors in a population-based cohort study. PloS one 8, e67175. https:\/\/doi.org\/10.1371\/journal.pone.0067175 (2013).","journal-title":"PloS one"},{"key":"87586_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1081\/prg-120029858","volume":"23","author":"CM Isler","year":"2004","unstructured":"Isler, C. M. et al. Septic pelvic thrombophlebitis and preeclampsia are related disorders. Hypertens. Pregnancy 23, 121\u2013127. https:\/\/doi.org\/10.1081\/prg-120029858 (2004).","journal-title":"Hypertens. Pregnancy"},{"key":"87586_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121130","volume":"310","author":"MA Ali","year":"2022","unstructured":"Ali, M. A. et al. Gestational NSAIDs distinctly reprogram cardiac injury in preeclamptic rats: Roles of cyclooxygenase, apoptotic and autophagic trails. Life sci. 310, 121130. https:\/\/doi.org\/10.1016\/j.lfs.2022.121130 (2022).","journal-title":"Life sci."},{"key":"87586_CR46","first-page":"349","volume":"40","author":"P Pandhi","year":"2002","unstructured":"Pandhi, P., Saha, L. & Malhotra, S. Effect of oral magnesium supplementation on experimental pre-eclampsia induced by prolonged blockade of nitric oxide synthesis in pregnant rats. Ind.J. exp. Boil. 40, 349\u2013351 (2002).","journal-title":"Ind.J. exp. Boil."},{"key":"87586_CR47","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2018.2.09","author":"M Kvandova","year":"2018","unstructured":"Kvandova, M. et al. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats. J. Physiol. Pharmacol.: An off. J. Polish Physiol. Soc. https:\/\/doi.org\/10.26402\/jpp.2018.2.09 (2018).","journal-title":"J. Physiol. Pharmacol.: An off. J. Polish Physiol. Soc."},{"key":"87586_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29271\/jcpsp.2018.01.31","volume":"28","author":"HIG Allam","year":"2018","unstructured":"Allam, H. I. G. & Masri, A. The potential therapeutic role of peroxisome ProliferatorActivated receptors agonist in Preeclamptic pregnant rats. J. Coll. Phys. Surg. Pak. 28, 31\u201335. https:\/\/doi.org\/10.29271\/jcpsp.2018.01.31 (2018).","journal-title":"J. Coll. Phys. Surg. Pak."},{"key":"87586_CR49","doi-asserted-by":"publisher","first-page":"8999","DOI":"10.1096\/fj.201900214R","volume":"33","author":"SL Lane","year":"2019","unstructured":"Lane, S. L. et al. Pharmacological activation of peroxisome proliferator-activated receptor \u03b3 (PPAR-\u03b3) protects against hypoxia-associated fetal growth restriction. FASEB J. 33, 8999\u20139007. https:\/\/doi.org\/10.1096\/fj.201900214R (2019).","journal-title":"FASEB J."},{"key":"87586_CR50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.111.172627","volume":"58","author":"FP McCarthy","year":"2011","unstructured":"McCarthy, F. P. et al. Peroxisome proliferator-activated receptor-\u03b3 as a potential therapeutic target in the treatment of preeclampsia. Hypertens. (Dallas, Tex.: 1979) 58, 280\u2013286. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.172627 (2011).","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"key":"87586_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2023.100647","author":"JH Mallette","year":"2023","unstructured":"Mallette, J. H., Crudup, B. F. & Alexander, B. T. Growth Restriction in Preeclampsia: Lessons from Animal Models. Curr. Opin. Physiol. https:\/\/doi.org\/10.1016\/j.cophys.2023.100647 (2023).","journal-title":"Curr. Opin. Physiol."},{"issue":"524","key":"87586_CR52","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/10641963.2018.1516773","volume":"41","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Ferulic acid ameliorated placental inflammation and apoptosis in rat with preeclampsia. Clin. Exp. Hypertens. (New York, N.Y.: 1993) 41(524), 530. https:\/\/doi.org\/10.1080\/10641963.2018.1516773 (2019).","journal-title":"Clin. Exp. Hypertens. (New York, N.Y.: 1993)"},{"key":"87586_CR53","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/s0002-9378(94)70179-2","volume":"170","author":"M Moln\u00e1r","year":"1994","unstructured":"Moln\u00e1r, M., S\u00fct\u00f6, T., T\u00f3th, T. & Hertelendy, F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am. J. obstet. Gynecol. 170, 1458\u20131466. https:\/\/doi.org\/10.1016\/s0002-9378(94)70179-2 (1994).","journal-title":"Am. J. obstet. Gynecol."},{"key":"87586_CR54","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1152\/ajpheart.00117.2012","volume":"303","author":"J Li","year":"2012","unstructured":"Li, J., LaMarca, B. & Reckelhoff, J. F. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am. J. physiol. Heart Circ. Physiol. 303, H1\u2013H8. https:\/\/doi.org\/10.1152\/ajpheart.00117.2012 (2012).","journal-title":"Am. J. physiol. Heart Circ. Physiol."},{"key":"87586_CR55","doi-asserted-by":"publisher","first-page":"F984","DOI":"10.1152\/ajprenal.00152.2016","volume":"311","author":"J Dolinina","year":"2016","unstructured":"Dolinina, J., Sverrisson, K., Rippe, A., \u00d6berg, C. M. & Rippe, B. Nitric oxide synthase inhibition causes acute increases in glomerular permeability in vivo, dependent upon reactive oxygen species. Am. J. Physiol. Ren. Physiol. 311, F984\u2013F990. https:\/\/doi.org\/10.1152\/ajprenal.00152.2016 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"87586_CR56","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1111\/j.1523-1755.2005.00744.x","volume":"68","author":"M Sharma","year":"2005","unstructured":"Sharma, M., McCarthy, E. T., Savin, V. J. & Lianos, E. A. Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide. Kidney Int. 68, 2735\u20132744. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00744.x (2005).","journal-title":"Kidney Int."},{"key":"87586_CR57","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/01.hyp.35.1.367","volume":"35","author":"JK Crews","year":"2000","unstructured":"Crews, J. K., Herrington, J. N., Granger, J. P. & Khalil, R. A. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertens. (Dallas, Tex.: 1979) 35, 367\u2013372. https:\/\/doi.org\/10.1161\/01.hyp.35.1.367 (2000).","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"key":"87586_CR58","doi-asserted-by":"publisher","first-page":"R505","DOI":"10.1152\/ajpregu.00137.2016","volume":"311","author":"M Zhu","year":"2016","unstructured":"Zhu, M., Ren, Z., Possomato-Vieira, J. S. & Khalil, R. A. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy. Am. J. physiol. Regul. Integr. Comp. Physiol. 311, R505\u2013R521. https:\/\/doi.org\/10.1152\/ajpregu.00137.2016 (2016).","journal-title":"Am. J. physiol. Regul. Integr. Comp. Physiol."},{"issue":"345","key":"87586_CR59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/hypertensionaha.109.132191","volume":"54","author":"SK Walsh","year":"2009","unstructured":"Walsh, S. K., English, F. A., Johns, E. J. & Kenny, L. C. Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: A microvascular characterization. Hypertens. (Dallas, Tex.: 1979) 54(345), 351. https:\/\/doi.org\/10.1161\/hypertensionaha.109.132191 (2009).","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"key":"87586_CR60","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1248\/bpb.b23-00234","volume":"46","author":"T Matsumoto","year":"2023","unstructured":"Matsumoto, T., Osada, T., Taguchi, K. & Kobayashi, T. Endothelial dysfunction in superior mesenteric arteries isolated from adenine-induced renal failure in model rats. Biol. Pharm. Bull. 46, 1156\u20131160. https:\/\/doi.org\/10.1248\/bpb.b23-00234 (2023).","journal-title":"Biol. Pharm. Bull."},{"key":"87586_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0014-2999(94)90386-7","volume":"254","author":"M Fahim","year":"1994","unstructured":"Fahim, M., el Mas, M. M., Abdel-Rahman, A. A. & Mustafa, S. J. Influence of aortic baroreceptor denervation on adenosine receptor-mediated relaxation of isolated rat aorta. Eur. J. pharmacol. 254, 183\u2013191. https:\/\/doi.org\/10.1016\/0014-2999(94)90386-7 (1994).","journal-title":"Eur. J. pharmacol."},{"key":"87586_CR62","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.bjp.0704140","volume":"133","author":"SM Hourani","year":"2001","unstructured":"Hourani, S. M., Boon, K., Fooks, H. M. & Prentice, D. J. Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues. Br. J. Pharmacol. 133, 833\u2013840. https:\/\/doi.org\/10.1038\/sj.bjp.0704140 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"87586_CR63","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1161\/01.cir.92.8.2135","volume":"92","author":"P Smits","year":"1995","unstructured":"Smits, P. et al. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 92, 2135\u20132141. https:\/\/doi.org\/10.1161\/01.cir.92.8.2135 (1995).","journal-title":"Circulation"},{"key":"87586_CR64","doi-asserted-by":"publisher","first-page":"H62","DOI":"10.1152\/ajpheart.1990.259.1.H62","volume":"259","author":"JP Headrick","year":"1990","unstructured":"Headrick, J. P. & Berne, R. M. Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am. J. physiol. 259, H62\u2013H67. https:\/\/doi.org\/10.1152\/ajpheart.1990.259.1.H62 (1990).","journal-title":"Am. J. physiol."},{"key":"87586_CR65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.brainresbull.2011.04.007","volume":"85","author":"D Bingham","year":"2011","unstructured":"Bingham, D., John, C. M., Panter, S. S. & Jarvis, G. A. Post-injury treatment with lipopolysaccharide or lipooligosaccharide protects rat neuronal and glial cell cultures. Brain res. Bull. 85, 403\u2013409. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.04.007 (2011).","journal-title":"Brain res. Bull."},{"key":"87586_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fncel.2020.00026","volume":"14","author":"M Sardari","year":"2020","unstructured":"Sardari, M. et al. Dose-dependent microglial and astrocytic responses associated with post-ischemic neuroprotection after lipopolysaccharide-induced sepsis-like state in mice. Front. Cell. Neurosci. 14, 26. https:\/\/doi.org\/10.3389\/fncel.2020.00026 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"87586_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27091","volume":"6","author":"Y Dai","year":"2016","unstructured":"Dai, Y. et al. miR-146a is essential for lipopolysaccharide (LPS)-induced cross-tolerance against kidney ischemia\/reperfusion injury in mice. Sci. Rep. 6, 1\u201312. https:\/\/doi.org\/10.1038\/srep27091 (2016).","journal-title":"Sci. Rep."},{"key":"87586_CR68","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11255-017-1735-3","volume":"50","author":"K He","year":"2018","unstructured":"He, K., Xia, L. & Zhang, J. LPS ameliorates renal ischemia\/reperfusion injury via Hsp27 up-regulation. Int. Urol. Nephrol. 50, 571\u2013580. https:\/\/doi.org\/10.1007\/s11255-017-1735-3 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"87586_CR69","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1742-2094-8-140","volume":"8","author":"KB Vartanian","year":"2011","unstructured":"Vartanian, K. B. et al. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflamm. 8, 140. https:\/\/doi.org\/10.1186\/1742-2094-8-140 (2011).","journal-title":"J. Neuroinflamm."},{"key":"87586_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174494","volume":"910","author":"SA Abuiessa","year":"2021","unstructured":"Abuiessa, S. A., El-Gowilly, S. M., El-Gowelli, H. M., Helmy, M. M. & El-Mas, M. M. Short-lived sensitization of cardiovascular outcomes of postpartum endotoxemia in preeclamptic rats: Role of medullary solitary tract neuroinflammation. Eur. J. pharmacol. 910, 174494. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174494 (2021).","journal-title":"Eur. J. pharmacol."},{"key":"87586_CR71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1124\/jpet.119.264192","volume":"373","author":"SA Abuiessa","year":"2020","unstructured":"Abuiessa, S. A., Wedn, A. M., El-Gowilly, S. M., Helmy, M. M. & El-Mas, M. M. Pre-eclamptic fetal programming alters neuroinflammatory and cardiovascular consequences of endotoxemia in sex-specific manners. J. pharmacol. Ex. Ther. 373, 325\u2013336. https:\/\/doi.org\/10.1124\/jpet.119.264192 (2020).","journal-title":"J. pharmacol. Ex. Ther."},{"key":"87586_CR72","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/s0735-1097(00)00933-5","volume":"36","author":"C Cheetham","year":"2000","unstructured":"Cheetham, C. et al. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J. Am. Coll. Cardiol. 36, 1461\u20131466. https:\/\/doi.org\/10.1016\/s0735-1097(00)00933-5 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"87586_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bcp.2010.11.013","volume":"81","author":"MM El-Mas","year":"2011","unstructured":"El-Mas, M. M. et al. Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function. Biochem. Pharmacol. 81, 526\u2013533. https:\/\/doi.org\/10.1016\/j.bcp.2010.11.013 (2011).","journal-title":"Biochem. Pharmacol."},{"key":"87586_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/bdra.20102","volume":"73","author":"S Alwan","year":"2005","unstructured":"Alwan, S., Polifka, J. E. & Friedman, J. M. Angiotensin II receptor antagonist treatment during pregnancy Birth Defects Research Part A: Clinical and Molecular. Teratology 73, 123\u2013130. https:\/\/doi.org\/10.1002\/bdra.20102 (2005).","journal-title":"Teratology"},{"key":"87586_CR75","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/14740338.2012.691963","volume":"11","author":"J Kung","year":"2012","unstructured":"Kung, J. & Henry, R. R. Thiazolidinedione safety. Expert. Opin. Drug saf. 11, 565\u2013579. https:\/\/doi.org\/10.1517\/14740338.2012.691963 (2012).","journal-title":"Expert. Opin. Drug saf."},{"key":"87586_CR76","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.arcmed.2011.08.003","volume":"42","author":"A Pineda","year":"2011","unstructured":"Pineda, A., Verdin-Ter\u00e1n, S. L., Camacho, A. & Moreno-Fierros, L. Expression of toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch. Med. Res. 42, 382\u2013391. https:\/\/doi.org\/10.1016\/j.arcmed.2011.08.003 (2011).","journal-title":"Arch. Med. Res."},{"key":"87586_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.883028","volume":"9","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. Programmed cell death in sepsis associated acute kidney injury. Front. Med. 9, 883028. https:\/\/doi.org\/10.3389\/fmed.2022.883028 (2022).","journal-title":"Front. Med."},{"issue":"958","key":"87586_CR78","first-page":"965","volume":"33","author":"TF Tang","year":"2008","unstructured":"Tang, T. F., Zhou, Q. L., Zhu, L. L., Tang, R. & Ao, X. Effects of fosinopril and losartan on the expression of Toll- like receptor 4 in renal tubular epithelia cells. Zhong nan da xue xue bao. Yi xue ban = J. Cent. South Univ. Med. Sci. 33(958), 965 (2008).","journal-title":"Zhong nan da xue xue bao. Yi xue ban = J. Cent. South Univ. Med. Sci."},{"key":"87586_CR79","first-page":"793","volume":"30","author":"Y Yu","year":"2014","unstructured":"Yu, Y., Wu, Y., Wen, G. & Yang, W. Effect of pioglitazone on the expression of TLR4 in renal tissue of diabetic rats. Xi bao yu fen zi mian yi xue za zhi = Chin. J. cell. Mol. Immunol. 30, 793\u2013797 (2014).","journal-title":"Xi bao yu fen zi mian yi xue za zhi = Chin. J. cell. Mol. Immunol."},{"key":"87586_CR80","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/fcp.12718","volume":"36","author":"A Al-Kadi","year":"2022","unstructured":"Al-Kadi, A., El-Daly, M., El-Tahawy, N. F. G., Khalifa, M. M. A. & Ahmed, A. F. Angiotensin aldosterone inhibitors improve survival and ameliorate kidney injury induced by sepsis through suppression of inflammation and apoptosis. Fund. Clin. Pharmacol. 36, 286\u2013295. https:\/\/doi.org\/10.1111\/fcp.12718 (2022).","journal-title":"Fund. Clin. Pharmacol."},{"key":"87586_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142303","volume":"10","author":"MM Helmy","year":"2015","unstructured":"Helmy, M. M., Helmy, M. W. & El-Mas, M. M. Additive renoprotection by pioglitazone and fenofibrate against inflammatory, oxidative and apoptotic manifestations of cisplatin nephrotoxicity: modulation by PPARs. PloS one 10, e0142303. https:\/\/doi.org\/10.1371\/journal.pone.0142303 (2015).","journal-title":"PloS one"},{"key":"87586_CR82","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1189\/jlb.0309189","volume":"86","author":"W Piao","year":"2009","unstructured":"Piao, W. et al. Endotoxin tolerance dysregulates MyD88- and Toll\/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. leukoc. Boil. 86, 863\u2013875. https:\/\/doi.org\/10.1189\/jlb.0309189 (2009).","journal-title":"J. leukoc. Boil."},{"key":"87586_CR83","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/00207454.2013.864289","volume":"124","author":"WC Li","year":"2014","unstructured":"Li, W. C. et al. Lipopolysaccharide preconditioning attenuates apoptotic processes and improves neuropathologic changes after spinal cord injury in rats. Int. j. neurosci. 124, 585\u2013592. https:\/\/doi.org\/10.3109\/00207454.2013.864289 (2014).","journal-title":"Int. j. neurosci."},{"key":"87586_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156724","volume":"182","author":"SM Aghaei","year":"2024","unstructured":"Aghaei, S. M. & Hosseini, S. M. Inflammation-related miRNAs in obesity, CVD, and NAFLD. Cytokine 182, 156724. https:\/\/doi.org\/10.1016\/j.cyto.2024.156724 (2024).","journal-title":"Cytokine"},{"key":"87586_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jcrc.2020.02.004","volume":"57","author":"I Cinel","year":"2020","unstructured":"Cinel, I., Kasapoglu, U. S., Gul, F. & Dellinger, R. P. The initial resuscitation of septic shock. J. crit. care 57, 108\u2013117. https:\/\/doi.org\/10.1016\/j.jcrc.2020.02.004 (2020).","journal-title":"J. crit. care"},{"key":"87586_CR86","doi-asserted-by":"crossref","unstructured":"El-Lakany, M. A., Wedn, A. M. & El-Mas, M. M. In Oxidative Stress in Cardiovascular-Metabolic Diseases 227\u2013296 (Springer, 2024).","DOI":"10.1007\/978-3-031-62131-4_9"},{"key":"87586_CR87","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2013.01.049","volume":"702","author":"HM El-Gowelli","year":"2013","unstructured":"El-Gowelli, H. M., El-Gowilly, S. M., Elsalakawy, L. K. & El-Mas, M. M. Nitric oxide synthase\/K+ channel cascade triggers the adenosine A(2B) receptor-sensitive renal vasodilation in female rats. Eur. J. pharmacol. 702, 116\u2013125. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.049 (2013).","journal-title":"Eur. J. pharmacol."},{"key":"87586_CR88","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0022-3565(25)21876-6","volume":"226","author":"T B\u00f6ke","year":"1983","unstructured":"B\u00f6ke, T. & Malik, K. U. Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney. J. Pharmacol. Exp.Ther. 226, 900\u2013907 (1983).","journal-title":"J. Pharmacol. Exp.Ther."},{"key":"87586_CR89","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ejphar.2008.04.048","volume":"588","author":"MM El-Mas","year":"2008","unstructured":"El-Mas, M. M., El-Gowilly, S. M., Gohar, E. Y. & Ghazal, A. R. Pharmacological characterization of cellular mechanisms of the renal vasodilatory effect of nicotine in rats. Eur. J. Pharmacol. 588, 294\u2013300. https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.048 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"87586_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2015.01.018","volume":"284","author":"MM El-Mas","year":"2015","unstructured":"El-Mas, M. M., Helmy, M. W., Ali, R. M. & El-Gowelli, H. M. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: Role of endothelin signaling. Toxicol. Appl. Pharmacol. 284, 1\u20137. https:\/\/doi.org\/10.1016\/j.taap.2015.01.018 (2015).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"87586_CR91","first-page":"957","volume":"78","author":"JM Pfeffer","year":"1971","unstructured":"Pfeffer, J. M., Pfeffer, M. A. & Frohlich, E. D. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J. lab. Clin. Med. 78, 957\u2013962 (1971).","journal-title":"J. lab. Clin. Med."},{"key":"87586_CR92","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/fjc.0000000000000993","volume":"77","author":"MY Sallam","year":"2021","unstructured":"Sallam, M. Y., El-Gowilly, S. M. & El-Mas, M. M. Cardiac and brainstem neuroinflammatory pathways account for androgenic incitement of cardiovascular and autonomic manifestations in endotoxic male rats. J. cardiovasc. Pharmacol. 77, 632\u2013641. https:\/\/doi.org\/10.1097\/fjc.0000000000000993 (2021).","journal-title":"J. cardiovasc. Pharmacol."},{"key":"87586_CR93","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12291-016-0551-3","volume":"31","author":"P Yalamati","year":"2016","unstructured":"Yalamati, P., Karra, M. L. & Bhongir, A. V. Comparison of urinary total proteins by four different methods. Ind. J. clin. Biochem.: IJCB 31, 463\u2013467. https:\/\/doi.org\/10.1007\/s12291-016-0551-3 (2016).","journal-title":"Ind. J. clin. Biochem.: IJCB"},{"key":"87586_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175344","volume":"936","author":"SA Abuiessa","year":"2022","unstructured":"Abuiessa, S. A., Helmy, M. M., El-Gowelli, H. M., El-Gowilly, S. M. & El-Mas, M. M. Dysregulated ACE\/Ang II\/Ang1-7 signaling provokes cardiovascular and inflammatory sequelae of endotoxemia in weaning preeclamptic rats. Eur. J. pharmacol. 936, 175344. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175344 (2022).","journal-title":"Eur. J. pharmacol."},{"key":"87586_CR95","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.lfs.2006.11.006","volume":"80","author":"GS Ceravolo","year":"2007","unstructured":"Ceravolo, G. S. et al. Enalapril and losartan restored blood pressure and vascular reactivity in intrauterine undernourished rats. Life sci. 80, 782\u2013787. https:\/\/doi.org\/10.1016\/j.lfs.2006.11.006 (2007).","journal-title":"Life sci."},{"key":"87586_CR96","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10557-008-6138-3","volume":"22","author":"Y Ye","year":"2008","unstructured":"Ye, Y., Lin, Y., Perez-Polo, J. R. & Birnbaum, Y. Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone. Cardiovasc. Drug. Ther. 22, 429\u2013436. https:\/\/doi.org\/10.1007\/s10557-008-6138-3 (2008).","journal-title":"Cardiovasc. Drug. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87586-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87586-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87586-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T06:13:11Z","timestamp":1741500791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87586-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87586"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87586-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Provided in methods.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations and approval for animal experiments"}}],"article-number":"8137"}}